Skip to main content
Fig. 7 | BMC Medical Genetics

Fig. 7

From: SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers

Fig. 7

Immunohistochemistry of cancer-free endometrial and endometrial cancer samples. Hematoxylin eosin staining (a, d, g, and j) and immunohistochemical staining of NFκB p65 (c, f, i, and l) and NFκB p50 (b, e, h, and k) in four endometrial cancer samples [Two were allele-specific expression (ASE) positive (+); the others were ASE negative (−)]. Scale bar = 50 μm

Back to article page